How have CINGW shares performed this year?

Cingulate's stock was trading at $0.03 at the beginning of 2024. Since then, CINGW shares have increased by 100.0% and is now trading at $0.06. View the best growth stocks for 2024 here .

How do I buy shares of Cingulate?

Shares of CINGW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CINGW

Cingulate (CINGW) Stock Price, News & Analysis

$0.07

0.00 (0.00%)

(As of 03:58 PM ET)

Compare

Today's Range: $0.05
▼
$0.08
50-Day Range: $0.01
▼
$0.18
52-Week Range: $0.00
▼
$0.30

Volume: 112,109 shs
Average Volume: 88,272 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Trends

Get Cingulate alerts:

Ad Brownstone Research

My big AI project…

On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.

Just click here to register.

About Cingulate

Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

CINGW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CINGW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive CINGW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cingulate and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:CINGW
CUSIP: N/A
CIK: 1862150
Web: www.cingulate.com
Phone: 913 942 2300
Fax: N/A
Employees: 13
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Dr. Shane J. Schaffer Pharm.D. (Age 49)
CEO & Chairman of the Board
Comp: $491.96k
Dr. Laurie A. Myers M.B.A. (Age 67)
Ph.D., Executive VP & COO
Comp: $415.17k
Dr. Matthew N. Brams M.D. (Age 60)
Executive VP & Chief Medical Officer
Comp: $244.79k
Ms. Jennifer L. Callahan CPA (Age 53)
Senior VP, CFO & Secretary
Dr. Raul R. Silva M.D. (Age 66)
Executive VP & Chief Science Officer
Thomas Dalton
Vice President of Investor & Public Relations

Key Competitors

View All Competitors

CINGW Stock Analysis - Frequently Asked Questions

How have CINGW shares performed this year?: Cingulate's stock was trading at $0.03 at the beginning of 2024. Since then, CINGW shares have increased by 100.0% and is now trading at $0.06.
View the best growth stocks for 2024 here.
How do I buy shares of Cingulate?: Shares of CINGW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.